6473 related articles for article (PubMed ID: 23348793)
21. Evaluation of arginine deiminase treatment in melanoma xenografts using (18)F-FLT PET.
Stelter L; Fuchs S; Jungbluth AA; Ritter G; Longo VA; Zanzonico P; Raschzok N; Sauer IM; Bomalaski JS; Larson SM
Mol Imaging Biol; 2013 Dec; 15(6):768-75. PubMed ID: 23722880
[TBL] [Abstract][Full Text] [Related]
22. Engineering an arginine catabolizing bioconjugate: Biochemical and pharmacological characterization of PEGylated derivatives of arginine deiminase from Mycoplasma arthritidis.
Wang M; Basu A; Palm T; Hua J; Youngster S; Hwang L; Liu HC; Li X; Peng P; Zhang Y; Zhao H; Zhang Z; Longley C; Mehlig M; Borowski V; Sai P; Viswanathan M; Jang E; Petti G; Liu S; Yang K; Filpula D
Bioconjug Chem; 2006; 17(6):1447-59. PubMed ID: 17105223
[TBL] [Abstract][Full Text] [Related]
23. Anti-tumor activity of arginine deiminase via arginine deprivation in retinoblastoma.
Kim JH; Kim JH; Yu YS; Kim DH; Min BH; Kim KW
Oncol Rep; 2007 Dec; 18(6):1373-7. PubMed ID: 17982619
[TBL] [Abstract][Full Text] [Related]
24. Arginine deprivation as a new treatment strategy for head and neck cancer.
Huang CC; Tsai ST; Kuo CC; Chang JS; Jin YT; Chang JY; Hsiao JR
Oral Oncol; 2012 Dec; 48(12):1227-35. PubMed ID: 22917549
[TBL] [Abstract][Full Text] [Related]
25. Enhancement of anti-tumor activity in melanoma using arginine deiminase fused with 30Kc19α protein.
Lee H; Park G; Kim S; Son B; Joo J; Park HH; Park TH
Appl Microbiol Biotechnol; 2022 Nov; 106(22):7531-7545. PubMed ID: 36227339
[TBL] [Abstract][Full Text] [Related]
26. Roles of nitric oxide synthase inhibition and vascular endothelial growth factor receptor-2 inhibition on vascular morphology and function in an in vivo model of pancreatic cancer.
Camp ER; Yang A; Liu W; Fan F; Somcio R; Hicklin DJ; Ellis LM
Clin Cancer Res; 2006 Apr; 12(8):2628-33. PubMed ID: 16638876
[TBL] [Abstract][Full Text] [Related]
27. Arginine Depletion Therapy with ADI-PEG20 Limits Tumor Growth in Argininosuccinate Synthase-Deficient Ovarian Cancer, Including Small-Cell Carcinoma of the Ovary, Hypercalcemic Type.
Ji JX; Cochrane DR; Tessier-Cloutier B; Chen SY; Ho G; Pathak KV; Alcazar IN; Farnell D; Leung S; Cheng A; Chow C; Colborne S; Negri GL; Kommoss F; Karnezis A; Morin GB; McAlpine JN; Gilks CB; Weissman BE; Trent JM; Hoang L; Pirrotte P; Wang Y; Huntsman DG
Clin Cancer Res; 2020 Aug; 26(16):4402-4413. PubMed ID: 32409304
[TBL] [Abstract][Full Text] [Related]
28. Recombinant arginine deiminase reduces inducible nitric oxide synthase iNOS-mediated neurotoxicity in a coculture of neurons and microglia.
Yu HH; Wu FL; Lin SE; Shen LJ
J Neurosci Res; 2008 Oct; 86(13):2963-72. PubMed ID: 18627024
[TBL] [Abstract][Full Text] [Related]
29. Modulation of arginine metabolic pathways as the potential anti-tumor mechanism of recombinant arginine deiminase.
Shen LJ; Beloussow K; Shen WC
Cancer Lett; 2006 Jan; 231(1):30-5. PubMed ID: 16356828
[TBL] [Abstract][Full Text] [Related]
30. Arginine deprivation using pegylated arginine deiminase has activity against primary acute myeloid leukemia cells in vivo.
Miraki-Moud F; Ghazaly E; Ariza-McNaughton L; Hodby KA; Clear A; Anjos-Afonso F; Liapis K; Grantham M; Sohrabi F; Cavenagh J; Bomalaski JS; Gribben JG; Szlosarek PW; Bonnet D; Taussig DC
Blood; 2015 Jun; 125(26):4060-8. PubMed ID: 25896651
[TBL] [Abstract][Full Text] [Related]
31. Comprehensive evaluation of the anti-angiogenic and anti-neoplastic effects of Endostar on liver cancer through optical molecular imaging.
Zhang Q; Du Y; Xue Z; Chi C; Jia X; Tian J
PLoS One; 2014; 9(1):e85559. PubMed ID: 24416426
[TBL] [Abstract][Full Text] [Related]
32. Phase I/II study of pegylated arginine deiminase (ADI-PEG 20) in patients with advanced melanoma.
Ott PA; Carvajal RD; Pandit-Taskar N; Jungbluth AA; Hoffman EW; Wu BW; Bomalaski JS; Venhaus R; Pan L; Old LJ; Pavlick AC; Wolchok JD
Invest New Drugs; 2013 Apr; 31(2):425-34. PubMed ID: 22864522
[TBL] [Abstract][Full Text] [Related]
33. Effect of molecular imaging on validation of developed anti-hVEGFR2 therapeutic antibody.
Cheong SJ; Lee CM; Jang D; Kim EM; Jeong MH; Uhm TB; Lee WS; Jeong HJ; Kim DW; Lim ST; Sohn MH
Cancer Biother Radiopharm; 2011 Dec; 26(6):745-51. PubMed ID: 22003972
[TBL] [Abstract][Full Text] [Related]
34. Recombinant human arginase inhibits the in vitro and in vivo proliferation of human melanoma by inducing cell cycle arrest and apoptosis.
Lam TL; Wong GK; Chow HY; Chong HC; Chow TL; Kwok SY; Cheng PN; Wheatley DN; Lo WH; Leung YC
Pigment Cell Melanoma Res; 2011 Apr; 24(2):366-76. PubMed ID: 21029397
[TBL] [Abstract][Full Text] [Related]
35. Exploiting Arginine Auxotrophy with Pegylated Arginine Deiminase (ADI-PEG20) to Sensitize Pancreatic Cancer to Radiotherapy via Metabolic Dysregulation.
Singh PK; Deorukhkar AA; Venkatesulu BP; Li X; Tailor R; Bomalaski JS; Krishnan S
Mol Cancer Ther; 2019 Dec; 18(12):2381-2393. PubMed ID: 31395686
[TBL] [Abstract][Full Text] [Related]
36. Adnectin CT-322 inhibits tumor growth and affects microvascular architecture and function in Colo205 tumor xenografts.
Ackermann M; Carvajal IM; Morse BA; Moreta M; O'Neil S; Kossodo S; Peterson JD; Delventhal V; Marsh HN; Furfine ES; Konerding MA
Int J Oncol; 2011 Jan; 38(1):71-80. PubMed ID: 21109927
[TBL] [Abstract][Full Text] [Related]
37. Combination therapy targeting the tumor microenvironment is effective in a model of human ocular melanoma.
Mangiameli DP; Blansfield JA; Kachala S; Lorang D; Schafer PH; Muller GW; Stirling DI; Libutti SK
J Transl Med; 2007 Jul; 5():38. PubMed ID: 17640369
[TBL] [Abstract][Full Text] [Related]
38. Longitudinal in vivo imaging of bone formation and resorption using fluorescence molecular tomography.
Lambers FM; Stuker F; Weigt C; Kuhn G; Koch K; Schulte FA; Ripoll J; Rudin M; Müller R
Bone; 2013 Feb; 52(2):587-95. PubMed ID: 23142804
[TBL] [Abstract][Full Text] [Related]
39. Arginine deiminase enhances MCF-7 cell radiosensitivity by inducing changes in the expression of cell cycle-related proteins.
Park H; Lee JB; Shim YJ; Shin YJ; Jeong SY; Oh J; Park GH; Lee KH; Min BH
Mol Cells; 2008 Apr; 25(2):305-11. PubMed ID: 18414006
[TBL] [Abstract][Full Text] [Related]
40. Multiple roles for platelet GPIIb/IIIa and alphavbeta3 integrins in tumor growth, angiogenesis, and metastasis.
Trikha M; Zhou Z; Timar J; Raso E; Kennel M; Emmell E; Nakada MT
Cancer Res; 2002 May; 62(10):2824-33. PubMed ID: 12019160
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
